FDA warns GLP-1s could increase risk of vision loss

The Food and Drug Administration is warning that GLP-1 medications may be linked to a rare eye condition that can cause permanent vision loss. Elaine Chen, biotech reporter with STAT, explains the findings and whether patients should be concerned.

Then, Nvidia’s stock price continues to fall as the scandal involving CEO Jensen Huang’s affair with an alleged Chinese spy unfolds. Matt Sheehan from the Carnegie Endowment for International Peace breaks down the implications for the U.S.-China artificial intelligence race.

And, California voters rejected a ballot measure that would have imposed a wealth tax on the state’s billionaires to fund health care. Marisa Lagos, reporter for KQED, details why the measure failed and what it means for future efforts to tax the wealthy.

See pcm.adswizz.com for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences.

NPR Privacy Policy